SHELLY FLOWERS: Open Payments
NPI 1386190627 · OLIVE BRANCH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 38 payments from 18 companies in 2025. Trend: 2023 $136 · 2024 $440 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $165 |
| PFIZER INC. | 6 | $117 |
| Exact Sciences Corporation | 3 | $50 |
| Astellas Pharma US Inc | 3 | $50 |
| SHIELD THERAPEUTICS INC | 2 | $43 |
| Corcept Therapeutics | 1 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
Products named: Ozempic, Wegovy, ELIQUIS, Cologuard Collection Kit, Veozah, ACCRUFER, PREVNAR 20, Korlym.
Industry payments across MS — which companies pay providers there.
